{
  "nodes": [
    {
      "id": 1,
      "label": "Prostate cancer",
      "properties": {
        "name": "Prostate cancer",
        "clinical_significance": "High",
        "evidence_level": "1a",
        "guideline_section": "Epidemiology and Risk Prevention",
        "publication_year": 2025
      }
    },
    {
      "id": 2,
      "label": "Age",
      "properties": {
        "name": "Age",
        "risk_factor_type": "Non-modifiable",
        "evidence_level": "1a",
        "guideline_section": "Epidemiology and Risk Prevention"
      }
    },
    {
      "id": 3,
      "label": "Racial differences",
      "properties": {
        "name": "Racial differences",
        "risk_factor_type": "Non-modifiable",
        "evidence_level": "1a",
        "guideline_section": "Epidemiology and Risk Prevention"
      }
    },
    {
      "id": 4,
      "label": "Genetic and epigenetic of prostate cancer",
      "properties": {
        "name": "Genetic and epigenetic of prostate cancer",
        "risk_factor_type": "Non-modifiable",
        "evidence_level": "1a",
        "guideline_section": "Epidemiology and Risk Prevention"
      }
    },
    {
      "id": 5,
      "label": "TNM prostate tumor staging",
      "properties": {
        "name": "TNM prostate tumor staging",
        "staging_version": "2017",
        "evidence_level": "1a",
        "guideline_section": "Classification and Staging Systems"
      }
    },
    {
      "id": 6,
      "label": "Digital rectal examination",
      "properties": {
        "name": "Digital rectal examination",
        "purpose": "Clinical T-stage assessment",
        "evidence_level": "1a",
        "guideline_section": "Classification and Staging Systems"
      }
    },
    {
      "id": 7,
      "label": "Needle Biopsy of Prostate",
      "properties": {
        "name": "Needle Biopsy of Prostate",
        "indication": "Elevated PSA detection",
        "evidence_level": "1a",
        "guideline_section": "Classification and Staging Systems"
      }
    },
    {
      "id": 8,
      "label": "T1c",
      "properties": {
        "name": "T1c",
        "definition": "Tumor identified by needle biopsy",
        "evidence_level": "1a",
        "staging_system": "TNM 2017"
      }
    },
    {
      "id": 9,
      "label": "Radical Prostatectomy",
      "properties": {
        "name": "Radical prostatectomy",
        "purpose": "Pathological staging confirmation",
        "evidence_level": "1a",
        "guideline_section": "Classification and Staging Systems"
      }
    },
    {
      "id": 10,
      "label": "Gleason Score for Prostate Cancer",
      "properties": {
        "name": "Gleason Score for Prostate Cancer",
        "grading_system": "ISUP/WHO 2022",
        "evidence_level": "1a",
        "guideline_section": "Classification and Staging Systems"
      }
    }
  ],
  "relationships": [
    {
      "from": 1,
      "to": 2,
      "type": "caused_by",
      "properties": {
        "evidence_level": "1a",
        "guideline_section": "Epidemiology and Risk Prevention"
      }
    },
    {
      "from": 1,
      "to": 3,
      "type": "caused_by",
      "properties": {
        "evidence_level": "1a",
        "guideline_section": "Epidemiology and Risk Prevention"
      }
    },
    {
      "from": 1,
      "to": 4,
      "type": "caused_by",
      "properties": {
        "evidence_level": "1a",
        "guideline_section": "Epidemiology and Risk Prevention"
      }
    },
    {
      "from": 6,
      "to": 5,
      "type": "participated_in",
      "properties": {
        "role": "Clinical T-stage determination",
        "evidence_level": "1a"
      }
    },
    {
      "from": 7,
      "to": 8,
      "type": "judge_by",
      "properties": {
        "diagnostic_criteria": "T1c definition",
        "evidence_level": "1a"
      }
    },
    {
      "from": 9,
      "to": 5,
      "type": "participated_in",
      "properties": {
        "role": "Pathological staging validation",
        "evidence_level": "1a"
      }
    },
    {
      "from": 8,
      "to": 1,
      "type": "stage_classify",
      "properties": {
        "clinical_significance": "Clinically significant categorization",
        "evidence_level": "1a"
      }
    },
    {
      "from": 10,
      "to": 1,
      "type": "disease_screening",
      "properties": {
        "purpose": "Tumor aggressiveness assessment",
        "evidence_level": "1a"
      }
    },
    {
      "from": 5,
      "to": 1,
      "type": "stage_classify",
      "properties": {
        "system_applicability": "Standard staging framework",
        "evidence_level": "1a"
      }
    }
  ]
}